'CAR T cell therapy for cancer: Pre-clinical delivery, clinical testing and post-clinical models to investigate CAR-T efficacy and toxicity issue'

In this section
'CAR T cell therapy for cancer: Pre-clinical delivery, clinical testing and post-clinical models to investigate CAR-T efficacy and toxicity issue'
-

This is a past event

Dr David Gilham, Institute of Cancer Sciences, University of Manchester

Immunity, Infection and Inflammation Seminar Programme